Advances in human stem cell-derived disease models have the potential to augment our predictive power for the efficacy and safety of new drugs. This technology, which complements existing approaches, ...
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
The stem cell therapy market size is expected to be worth USD 59.70 billion by 2035, increasing from USD 18.13 billion in ...
Pharma giant GSK is launching a five-year collaboration with The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) to advance human cellular models of neurodegenerative ...
The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of ...
AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...
The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research ...
A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...
There is a high unmet need for accessible, affordable, and high-quality fertility care, as approximately 1 in 6 people are affected by infertility worldwide. While meiotic failure is a major cause of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results